Premium
A problem of control of treatment in a boy with salt‐losing congenital adrenal hyperplasia (21‐hydroxylation defect)
Author(s) -
Darling J. A. B.,
Fraser N. C.
Publication year - 1981
Publication title -
journal of inherited metabolic disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.462
H-Index - 102
eISSN - 1573-2665
pISSN - 0141-8955
DOI - 10.1007/bf02263638
Subject(s) - congenital adrenal hyperplasia , mineralocorticoid , endocrinology , medicine , glucocorticoid , hydroxyprogesterone , hydroxylation , urinary system , hyperplasia , steroid , chemistry , hormone , enzyme , biochemistry
Abstract Inadequate mineralocorticoid replacement is shown to have been the cause of elevated levels of plasma ACTH and 17α‐hydroxyprogesterone and of urinary steroids in a boy with salt‐losing congenital adrenal hyperplasia who was receiving more than adequate glucocorticoid replacement.